આજે CUMMINSIND, APOLLOTYRE, IRCTC, NAUKRI, POWERGRID, ZYDUSLIFE જાહેર કરશે પરીણામ
અમદાવાદ, 7 નવેમ્બરઃ Q2FY24 EARNING કેલેન્ડરનો અંતિમ તબક્કો ચાલી રહ્યો છે. જેમાં આજે CUMMINSIND, APOLLOTYRE, IRCTC, NAUKRI, POWERGRID, ZYDUSLIFE સહિતની કંપનીઓ જાહેર કરશે પરીણામ. અગ્રણી બ્રોકરેજ હાઉસિસ, માર્કેટ નિષ્ણાતોએ જાહેર કરેલા અનુમાનો અત્રે રજૂ કર્યાછે. જેના આધારે રોકાણકારો અભ્યાસ અને માહિતી મેળવીને ટ્રેડિંગ સ્ટ્રેટેજી ગોઠવી શકે.
Q2FY24 EARNING CALENDAR 07.11.2023: AARTIPHARM, ALKEM, ALKYLAMINE, ANURAS, APLLTD, APOLLOTYRE, ARVINDFASN, ATULAUTO, AVANTI, BALMLAWRIE, BALRAMCHIN, CARYSIL, COCHINSHIP, CRISIL, CUMMINSIND, DBL, DBREALTY, DEEPAKNI, DEVYANI, DOLLAR, EVEREADY, GHCL, GREAVESCOT, GSFC, HARSHA, HAWKINCOOK, HESTERBIO, HIMATSEIDE, IDEAFORGE, IRCTC, ITDC, JYOTHYLAB, KIRLOSBROS, KOPRAN, LIKHITHA, LUMAXIND, LUXIND, MAFATIND, MANALIPETC, MIDHANI, NAUKRI, NEULANDLAB, POWERGRID, PRAKASH, PRESTIGE, PRINCEPIPE, RAIN, ROLEXRINGS, SAINTGOBAIN, SALASAR, SANGHVIMOV, SCHNEIDER, SHREECEM, SJS, SKIPPER, STOVEKRAFT, TRENT, UDS, UNOMINDA, VARROC, VIJAYA, VSSL, VSTTILLERS, YATHARTH, ZAGGLE, ZYDUSLIFE
ALKEM
Revenue expected at Rs 3350 crore versus Rs 3079 crore
EBITDA expected to be seen at Rs 506 crore versus Rs 453 crore
EBITDA margin expected to be seen at 15.1% versus 14.7%
Net profit expected to be seen at Rs 375 crore versus of Rs 330 crore
APOLLOTYRE
Revenue expected at Rs 6337 crore versus Rs 5956 crore
EBITDA expected to be seen at Rs 1057 crore versus Rs 712 crore
EBITDA margin expected to be seen at 16.6% versus 11.9%
Net profit expected to be seen at Rs 430 crore versus of Rs 194 crore
CUMMINSIND
Revenue expected at Rs 1993 crore versus Rs 1957 crore
EBITDA expected to be seen at Rs 281 crore versus Rs 322 crore
EBITDA margin expected to be seen at 14.1% versus 16.4%
Net profit expected to be seen at Rs 257 crore versus of Rs 267 crore
DEEPAKNI
Revenue expected at Rs 1939 crore versus Rs 1962 crore
EBITDA expected to be seen at Rs 235 crore versus Rs 271 crore
EBITDA margin expected to be seen at 12.1% versus 13.8%
Net profit expected to be seen at Rs 143 crore versus of Rs 175 crore
IRCTC
Revenue expected at Rs 1074 crore versus Rs 805 crore
EBITDA expected to be seen at Rs 369 crore versus Rs 472 crore
EBITDA margin expected to be seen at 34.3% versus 58.5%
Net profit expected to be seen at Rs 299 crore versus of Rs 226 crore
NAUKRI
Revenue expected at Rs 605 crore versus Rs 625 crore
EBIT expected to be seen at Rs 215 crore versus Rs 178 crore
EBIT margin expected to be seen at 35.5% versus 21.1%
Net profit expected to be seen at Rs 207 crore versus of Rs 158 crore
POWERGRID
Revenue expected at Rs 11,945 crore versus Rs 10,656 crore
EBITDA expected to be seen at Rs 10,315 crore versus Rs 8958 crore
EBITDA margin expected to be seen at 86.4% versus 84.0%
Net profit expected to be seen at Rs 3897 crore versus of Rs 3685 crore
SHREECEM
Revenue expected at Rs 4507 crore versus Rs 4039 crore
EBITDA expected to be seen at Rs 862 crore versus Rs 542 crore
EBITDA margin expected to be seen at 19.1% versus 13.5%
Net profit expected to be seen at Rs 355 crore versus of Rs 183 crore
TRENT
Revenue expected at Rs 2630 crore versus Rs 1814 crore
EBITDA expected to be seen at Rs 375 crore versus Rs 268 crore
EBITDA margin expected to be seen at 14.3% versus 14.8%
Net profit expected to be seen at Rs 173 crore versus of Rs 186 crore
UNOMINDA
Revenue expected at Rs 3477 crore versus Rs 2876 crore
EBITDA expected to be seen at Rs 387 crore versus Rs 318 crore
EBITDA margin expected to be seen at 11.1% versus 11.0%
Net profit expected to be seen at Rs 212 crore versus of Rs 170 crore
ZYDUSLIFE
Revenue expected at Rs 4655 crore versus Rs 4134 crore
EBITDA expected to be seen at Rs 1108 crore versus Rs 815 crore
EBITDA margin expected to be seen at 23.8% versus 19.7%
Net profit expected to be seen at Rs 746 crore versus of Rs 517 crore
Q2FY24 EARNING CALENDAR 08.11.2023: 63MOONS, ALEMBICLTD, ARTEMISMED, ASHOKA, AVADHSUGAR, BALAMINES, BATAINDIA, BHEL, BOROLTD, CAMS, CENTURYPLY, CESC, CONCORDBIO, DCAL, EASEMYTRIP, EIDPARRY, ELGIEQUIP, EMUDHRA, FDC, GNFC, GPPL, GODREJIND, GENSOL, GRINDWELL, GUJALKALI, HEG, HMAAGRO, HPL, IFCI, IOLCP, ITDCEM, KIOCL, KSCL, LANDMARK, LUPIN, MAZDOCK, MCX, MEDPLUS, MOIL, MTARTECH, MUNJALSHOW, NEOGEN, NAZARA, OIL, PATANJALI, PAUSHAKLTD, PHOENIXLTD, PFC, PIDILITIND, PIIND, PRICOLLTD, RENUKA, RAYMOND, RICOAUTO, SAMHI, SANOFI, SANSERA, SKFINDIA, TAJGVK, TALBROAUTO, TASTYBIT, TATAINVEST, TATAPOWER, TDPOWERSYS, UGARSUGAR, UNITDSPR, WELCORP, WONDERLA
(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)
(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ, ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)
